States can use about 10,000 hospitals under Ayushman Bharat-PMJAY and 687 hospitals under CGHS as Covid-19 vaccination centers, according to the government (CVCs).
People over 60 years of age and those over 45 years of age with co-morbidities are registered for the second phase of the coronavirus disease (Covid-19) vaccination campaign, which begins Monday. For this process of inoculation, which is projected to cover 270 million people, the government has also enlisted the support of private hospitals. Although the vaccine will be given free of charge in government hospitals, the price of the shot in private hospitals has been set at $250 by the Centre.
For people aged 45 to 59 years, the government has recorded 20 co-morbidities. Those with co-morbidities must present a one-page certificate signed by any licenced physician. The certificate can be submitted on Co-WIN2.0 by the beneficiary when self-registering, or the beneficiary can bring a hard copy to the CVC, according to the health ministry.
Congenital heart disease, which induces pulmonary arterial hypertension, end-stage kidney disease, or cancers such as lymphoma, leukaemia, and myloma, decompensated liver cirrhosis (liver function deterioration due to scarring), primary immune deficiency disorders, and sickle cell anaemia are among the conditions.
States were told about three methods of registration for those who wanted to get the vaccine at this stage: advance self-registration, onsite registration, and facilitated cohort registration.
The states have been asked to provide private centres with login credentials for the modified Co-WIN network, which the government says is the cornerstone of India's immunisation drive. It's a digital portal where someone who wants a dose must first sign up.
States can use about 10,000 hospitals under Ayushman Bharat-PMJAY and 687 hospitals under CGHS as Covid-19 vaccination centres, according to the government (CVCs). There will also be government health facilities that will function as CVCs, such as medical college hospitals, district hospitals, sub-divisional hospitals, CHCs, PHCs, health sub-centres, and health and wellness centres, according to the Union Ministry of Health and Family Welfare. Geo reference maps with GPS coordinates of all these health facilities that will serve as CVCs have been prepared.
In India, two vaccines are currently being used: Covishield, produced by Oxford-AstraZeneca and manufactured by SII, and Covaxin, developed and manufactured by Bharat Biotech.
Only health and frontline staff were included in the first phase of the vaccination campaign, which began on January 16. By Saturday evening, 14,242,547 doses of the vaccine had been administered.
